Focused issue on testicular cancer—forward

Focused issue on testicular cancer—forward

Testicular cancer is the most common solid tumor in young adult men and the incidence is increasing across most parts of the world. Although the overall incidence to mortality ratio is very favorable, successful oncologic outcomes require a careful understanding of stage and risk-dependent management strategies, as well as knowledge regarding the appropriate integration of surgical and systemic therapies. Furthermore, a greater understanding of immediate and long-term side effects to different therapeutic modalities has in part been responsible for a renewed focus towards minimizing the therapeutic burden required to maintain high cure rates while sparing patients the associated intermediate and long-term sequelae of cancer-directed therapies.

A comprehensive approach to treating patients with testis cancer requires a collaborative group of medical professionals spanning various disciplines. This focused issue on testicular cancer addresses some of the most current concepts in multidisciplinary care. Invited experts in the field of testicular cancer address numerous topics including; radiographic studies for diagnosis and staging, fertility considerations and testis preservation strategies, high-risk features in men with stage I tumors, current stage-dependent therapeutic concepts for patients with seminoma and non-seminoma germ cell tumors as well as uncommon testis cancer histologies, minimally invasive surgical strategies as well as multidisciplinary concepts in the post-chemotherapy and surgical-salvage settings, and minimally invasive methods to manage postoperative lymphatic leaks.

We are indebted to numerous colleagues who contributed to this academic effort, as well as to the Editorial Team at TAU who made this focused issue possible.




Conflicts of Interest: The authors have no conflicts of interest to declare.

Ethical Statement: The authors are accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

Wade J. Sexton
Scott M. Gilbert

Wade J. Sexton, MD

Scott M. Gilbert, MD

Department of Genitourinary Oncology, Moffitt Cancer Center, Tampa, FL, USA

doi: 10.21037/tau.2019.12.15

Cite this article as: Sexton WJ, Gilbert SM. Focused issue on testicular cancer—forward. Transl Androl Urol 2020;9(Suppl 1):S1-S2. doi: 10.21037/tau.2019.12.15